Copyright © 1988 by the European Society of Cardiology.
© 1988 The European Society of Cardiology
Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment
*Department of Medicine, Division of Cardiology University Hospital Frankfurt a.M., F.R.G.
Department of Radiology, Division of Nuclear Medicine University Hospital Frankfurt a.M., F.R.G.
Received 4 August 1986; revised 10 August 1987; .
address for correspondence: Dr med. W. Schneider, Zentrum der Inneren Medizin, Abteilung fur Kardiologie, Klinikum der Johann Wolfgang Goethe-Universitãt, Theodor-Stern-Kai 7, D-6000 Frankfurt a. M 70, Federal Republic of Germany.
Abstract
Fourteen male patients with exertion-related angina pectoris and reproducible ST-segment depression on stress testing were each treated with isosorbide dinitrate (ISDN) 40 mg three times daily, verapamil 120 mg three times daily and placebo three times daily for two weeks according to a double-blind cross-over protocol.
The mean improvement of exercise-induced ST-segment depression amounted to 73% on the first day of ISDN treatment (P < 0.001) and to 54% following acute administration of verapamil (P < 0.001). On the last day of continuous treatment, the antianginal efficacy of ISDN was somewhat mitigated (reduction of ST-segment depression: 54%; P<0.001), while the effect of verapamil remained unchanged (55%, P<0.001). The double product (heart rate x systolic blood pressure) at the end of stress testing decreased most pronouncedly on day 1 of ISDN treatment ( - 21%; P<0.01). On chronic testing, both drugs similarly influenced this parameter: 10–11% (P<0.05). The mean global ejection fraction (EF) assessed by gated blood pool scintigraphy on day 13 showed a stress-induced fall from 49 to 44% (P<0.05) after the administration of placebo. The respective values with ISDN were 53% at rest and 52% on exercise (n.s.), and after giving verapamil 50% and47% (n.s.).
Thus, ISDN 40 mg and verapamil 120 mg displayed beneficial anti-ischaemic effects in patients with stable exertion-related angina pectoris after acute and chronic administration. The efficacy of ISDN declined somewhat in the course of the two-week treatment, whereas that of verapamil remained unchanged. Beneficial effects of both drugs were also demonstrated with regard to the rate pressure product. Isosorbide dinitrate 40 mg and verapamil 120 mg administered three times daily can be recommended for the acute and chronic therapy of patients with stable angina.
Key Words: Isosorbide dinitrate • verapamil • stable angina pectoris • acute • chronic efficacy • myocardial ischaemia.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. D. Fihn, S. V. Williams, J. Daley, and R. J. Gibbons Guidelines for the Management of Patients with Chronic Stable Angina: Treatment Ann Intern Med, October 16, 2001; 135(8_Part_1): 616 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Heidenreich, K. M. McDonald, T. Hastie, B. Fadel, V. Hagan, B. K. Lee, and M. A. Hlatky Meta-analysis of Trials Comparing {beta}-Blockers, Calcium Antagonists, and Nitrates for Stable Angina JAMA, May 26, 1999; 281(20): 1927 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Karnik, A. Valentin, G. Bonner, B. Ziegler, and J. Slany Transcranial Doppler Monitoring During Percutaneous Transluminal Aortic Valvuloplasty Angiology, February 1, 1990; 41(2): 106 - 111. [Abstract] [PDF]
|
|